世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ラテンアメリカのセルライト治療市場 2023-2030

ラテンアメリカのセルライト治療市場 2023-2030


LATIN AMERICA CELLULITE TREATMENT MARKET 2023-2030

市場の展望 Tritonのレポートによると、ラテンアメリカのセルライト治療市場は、予測期間2023-2030年に8.92％の複合年間成長率で進展すると推定されます。この地域では、ブラジル、メキシコ、ラテンアメリカの残... もっと見る

　

　

出版社 出版年月 電子版価格 納期 ページ数 言語
Triton Market Research
トリトンマーケットリサーチ 		2023年5月2日 US$1,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		3-5営業日程度 104 英語

　

サマリー

市場の展望
Tritonのレポートによると、ラテンアメリカのセルライト治療市場は、予測期間2023-2030年に8.92％の複合年間成長率で進展すると推定されます。この地域では、ブラジル、メキシコ、ラテンアメリカの残りの地域が考慮されています。
アルゼンチンでは、費用対効果が高く、高度な施術が受けられることから、近年、医療観光部門が大きく注目されています。業界筋によると、約2000人の形成外科医が同国で活動しています。さらに、チリは、医療観光の目的地として最も好まれる国となっています。したがって、医療観光産業の活況と美容施術の増加は、ラテンアメリカの残りの地域でセルライト治療市場の成長機会を生み出すと期待されています。
さらに、高級医療施設が充実していることが、メキシコの医療観光産業の成長を加速させています。この点で、複数の患者がセルライト治療を含む外見を向上させるために高度な美容整形を希望しています。また、老年人口の増加により、皮膚の緩みに対処するためのセルライト除去治療に対する需要も高まっています。このように、これらすべての要因が、セルライト治療市場を成長軌道に乗せているのです。

競争展望
セルライト治療市場に上場している著名な企業には、ジョンソン・エンド・ジョンソン、Cutera Inc、Inceler Medikal、Galderma SA、Endo International Plcがあります。


ページTOPに戻る


目次

TABLE OF CONTENTS
1. LATIN AMERICA CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1.PARENT MARKET ANALYSIS
2.2.IMPACT ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1.COVID-19 IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2.UKRAINE-RUSSIA WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3.PORTER’S FIVE FORCES ANALYSIS
2.3.1.THREAT OF NEW ENTRANTS
2.3.2.THREAT OF SUBSTITUTES
2.3.3.BARGAINING POWER OF BUYERS
2.3.4.BARGAINING POWER OF SUPPLIERS
2.3.5.THREAT OF COMPETITIVE RIVALRY
2.4.MARKET MATURITY ANALYSIS
2.5.INDUSTRY COMPONENTS
2.5.1.RESEARCH AND DEVELOPMENT
2.5.2.MANUFACTURING OF PRODUCT
2.5.3.DISTRIBUTION
2.5.4.POST-SALES MONITORING
2.6.REGULATORY FRAMEWORK
2.7.KEY BUYING IMPACT ANALYSIS
2.7.1.PRICE
2.7.2.BRAND NAME
2.7.3.USABILITY
2.8.KEY MARKET STRATEGIES
2.8.1.COLLABORATIONS
2.8.2.PRODUCT LAUNCHES
2.8.3.MERGERS & ACQUISITIONS
2.8.4.BUSINESS DIVESTITURES & EXPANSIONS
2.9.MARKET DRIVERS
2.9.1.GROWING PREVALENCE OF OBESITY
2.9.2.RAPIDLY GROWING MEDICAL TOURISM SECTOR
2.9.3.RISING DEMAND FOR AESTHETIC PROCEDURES
2.10.MARKET CHALLENGES
2.10.1.LACK OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2.HIGH PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3.RISKS ASSOCIATED POST-TREATMENT
2.11.MARKET OPPORTUNITIES
2.11.1.RISING BEAUTY CONSCIOUSNESS
2.11.2.INCREASING TREND OF ANTI-CELLULITE MASSAGE
2.11.3.GROWING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4.RISING POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5.ADVANCEMENTS IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12.ANALYST PERSPECTIVE
3. LATIN AMERICA CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1.SOFT CELLULITE
3.2.HARD CELLULITE
3.3.EDEMATOUS CELLULITE
4. LATIN AMERICA CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1.NON-INVASIVE
4.2.MINIMALLY INVASIVE
4.3.TOPICAL
5. LATIN AMERICA CELLULITE TREATMENT MARKET – BY END-USER
5.1.HOSPITALS
5.2.CLINICS AND BEAUTY CENTERS
5.3.OTHER END-USERS
6. LATIN AMERICA CELLULITE TREATMENT MARKET – BY COUNTRY OUTLOOK
6.1.COUNTRY ANALYSIS
6.1.1.BRAZIL
6.1.1.1.BRAZIL CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.2.MEXICO
6.1.2.1.MEXICO CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.3.REST OF LATIN AMERICA
6.1.3.1.REST OF LATIN AMERICA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE LANDSCAPE
7.1.JOHNSON & JOHNSON
7.1.1.OVERVIEW
7.1.2.PRODUCT PORTFOLIO
7.1.3.KEY STRENGTHS
7.1.4.KEY CHALLENGES
7.2.ABBVIE INC
7.2.1.OVERVIEW
7.2.2.PRODUCT PORTFOLIO
7.2.3.KEY STRENGTHS
7.2.4.KEY CHALLENGES
7.3.BAUSCH HEALTH COMPANIES INC
7.3.1.OVERVIEW
7.3.2.PRODUCT PORTFOLIO
7.3.3.KEY STRENGTHS
7.3.4.KEY CHALLENGES
7.4.CUTERA INC
7.4.1.OVERVIEW
7.4.2.PRODUCT PORTFOLIO
7.4.3.KEY STRENGTHS
7.4.4.KEY CHALLENGES
7.5.INCELER MEDIKAL
7.5.1.OVERVIEW
7.5.2.PRODUCT PORTFOLIO
7.5.3.KEY STRENGTHS
7.5.4.KEY CHALLENGES
7.6.ZIMMER MEDIZINSYSTEME GMBH
7.6.1.OVERVIEW
7.6.2.PRODUCT PORTFOLIO
7.6.3.KEY STRENGTHS
7.6.4.KEY CHALLENGES
7.7.GALDERMA SA
7.7.1.OVERVIEW
7.7.2.PRODUCT PORTFOLIO
7.7.3.KEY STRENGTHS
7.7.4.KEY CHALLENGES
7.8.SIENTRA INC
7.8.1.OVERVIEW
7.8.2.PRODUCT PORTFOLIO
7.8.3.KEY STRENGTHS
7.8.4.KEY CHALLENGES
7.9.ENDO INTERNATIONAL PLC
7.9.1.OVERVIEW
7.9.2.PRODUCT PORTFOLIO
7.9.3.KEY STRENGTHS
7.9.4.KEY CHALLENGES
7.10.CANDELA MEDICAL CORPORATION
7.10.1.OVERVIEW
7.10.2.PRODUCT PORTFOLIO
7.10.3.KEY STRENGTHS
7.10.4.KEY CHALLENGES
8. RESEARCH METHODOLOGY & SCOPE
8.1.RESEARCH SCOPE & DELIVERABLES
8.1.1.OBJECTIVES OF STUDY
8.1.2.SCOPE OF STUDY
8.2.SOURCES OF DATA
8.2.1.PRIMARY DATA SOURCES
8.2.2.SECONDARY DATA SOURCES
8.3.RESEARCH METHODOLOGY
8.3.1.EVALUATION OF THE PROPOSED MARKET
8.3.2.IDENTIFICATION OF DATA SOURCES
8.3.3.ASSESSMENT OF MARKET DETERMINANTS
8.3.4.DATA COLLECTION
8.3.5.DATA VALIDATION & ANALYSIS

TABLE LIST
TABLE 1: LATIN AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: LATIN AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: LATIN AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: LATIN AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: LATIN AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

FIGURE LIST
FIGURE 1: MARKET MATURITY ANALYSIS
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: KEY BUYING IMPACT ANALYSIS
FIGURE 4: LATIN AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)
FIGURE 5: LATIN AMERICA CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 6: LATIN AMERICA CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 7: LATIN AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)
FIGURE 8: LATIN AMERICA CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 9: LATIN AMERICA CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 10: LATIN AMERICA CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: LATIN AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: LATIN AMERICA CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: LATIN AMERICA CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030 (IN $ MILLION)
FIGURE 14: LATIN AMERICA CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 15: LATIN AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: BRAZIL CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: MEXICO CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: REST OF LATIN AMERICA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)

ページTOPに戻る



図表リスト

TABLE LIST
TABLE 1: LATIN AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: LATIN AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: LATIN AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: LATIN AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: LATIN AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

　

ページTOPに戻る


　

Summary

MARKET OUTLOOK
As per Triton’s report, the Latin America cellulite treatment market is estimated to progress with a compound annual growth rate of 8.92% during the forecast period 2023-2030. Brazil, Mexico, and Rest of Latin America are taken into consideration in the region.
In Argentina, the medical tourism sector has gained significant prominence over recent years, owing to cost-effective and advanced procedures. As per industry sources, around 2000 plastic surgeons operate in the country. Further, Chile has also emerged as the most preferred medical tourist destination. Hence, the booming medical tourism industry and rising cosmetic procedures are expected to generate growth opportunities for the cellulite treatment market across the Rest of Latin America.
Furthermore, the availability of premium healthcare facilities has accelerated the growth of the medical tourism industry across Mexico. In this regard, several patients seek advanced cosmetic procedures to enhance their appearance, including cellulite treatment. The rise in the geriatric population has also increased the demand for cellulite reduction treatments to address loose skin. All these factors are thus propelling the cellulite treatment market on a growth path.

COMPETITIVE OUTLOOK
The eminent companies listed in the cellulite treatment market include Johnson & Johnson, Cutera Inc, Inceler Medikal, Galderma SA, and Endo International Plc.



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1. LATIN AMERICA CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1.PARENT MARKET ANALYSIS
2.2.IMPACT ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1.COVID-19 IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2.UKRAINE-RUSSIA WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3.PORTER’S FIVE FORCES ANALYSIS
2.3.1.THREAT OF NEW ENTRANTS
2.3.2.THREAT OF SUBSTITUTES
2.3.3.BARGAINING POWER OF BUYERS
2.3.4.BARGAINING POWER OF SUPPLIERS
2.3.5.THREAT OF COMPETITIVE RIVALRY
2.4.MARKET MATURITY ANALYSIS
2.5.INDUSTRY COMPONENTS
2.5.1.RESEARCH AND DEVELOPMENT
2.5.2.MANUFACTURING OF PRODUCT
2.5.3.DISTRIBUTION
2.5.4.POST-SALES MONITORING
2.6.REGULATORY FRAMEWORK
2.7.KEY BUYING IMPACT ANALYSIS
2.7.1.PRICE
2.7.2.BRAND NAME
2.7.3.USABILITY
2.8.KEY MARKET STRATEGIES
2.8.1.COLLABORATIONS
2.8.2.PRODUCT LAUNCHES
2.8.3.MERGERS & ACQUISITIONS
2.8.4.BUSINESS DIVESTITURES & EXPANSIONS
2.9.MARKET DRIVERS
2.9.1.GROWING PREVALENCE OF OBESITY
2.9.2.RAPIDLY GROWING MEDICAL TOURISM SECTOR
2.9.3.RISING DEMAND FOR AESTHETIC PROCEDURES
2.10.MARKET CHALLENGES
2.10.1.LACK OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2.HIGH PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3.RISKS ASSOCIATED POST-TREATMENT
2.11.MARKET OPPORTUNITIES
2.11.1.RISING BEAUTY CONSCIOUSNESS
2.11.2.INCREASING TREND OF ANTI-CELLULITE MASSAGE
2.11.3.GROWING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4.RISING POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5.ADVANCEMENTS IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12.ANALYST PERSPECTIVE
3. LATIN AMERICA CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1.SOFT CELLULITE
3.2.HARD CELLULITE
3.3.EDEMATOUS CELLULITE
4. LATIN AMERICA CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1.NON-INVASIVE
4.2.MINIMALLY INVASIVE
4.3.TOPICAL
5. LATIN AMERICA CELLULITE TREATMENT MARKET – BY END-USER
5.1.HOSPITALS
5.2.CLINICS AND BEAUTY CENTERS
5.3.OTHER END-USERS
6. LATIN AMERICA CELLULITE TREATMENT MARKET – BY COUNTRY OUTLOOK
6.1.COUNTRY ANALYSIS
6.1.1.BRAZIL
6.1.1.1.BRAZIL CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.2.MEXICO
6.1.2.1.MEXICO CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.3.REST OF LATIN AMERICA
6.1.3.1.REST OF LATIN AMERICA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE LANDSCAPE
7.1.JOHNSON & JOHNSON
7.1.1.OVERVIEW
7.1.2.PRODUCT PORTFOLIO
7.1.3.KEY STRENGTHS
7.1.4.KEY CHALLENGES
7.2.ABBVIE INC
7.2.1.OVERVIEW
7.2.2.PRODUCT PORTFOLIO
7.2.3.KEY STRENGTHS
7.2.4.KEY CHALLENGES
7.3.BAUSCH HEALTH COMPANIES INC
7.3.1.OVERVIEW
7.3.2.PRODUCT PORTFOLIO
7.3.3.KEY STRENGTHS
7.3.4.KEY CHALLENGES
7.4.CUTERA INC
7.4.1.OVERVIEW
7.4.2.PRODUCT PORTFOLIO
7.4.3.KEY STRENGTHS
7.4.4.KEY CHALLENGES
7.5.INCELER MEDIKAL
7.5.1.OVERVIEW
7.5.2.PRODUCT PORTFOLIO
7.5.3.KEY STRENGTHS
7.5.4.KEY CHALLENGES
7.6.ZIMMER MEDIZINSYSTEME GMBH
7.6.1.OVERVIEW
7.6.2.PRODUCT PORTFOLIO
7.6.3.KEY STRENGTHS
7.6.4.KEY CHALLENGES
7.7.GALDERMA SA
7.7.1.OVERVIEW
7.7.2.PRODUCT PORTFOLIO
7.7.3.KEY STRENGTHS
7.7.4.KEY CHALLENGES
7.8.SIENTRA INC
7.8.1.OVERVIEW
7.8.2.PRODUCT PORTFOLIO
7.8.3.KEY STRENGTHS
7.8.4.KEY CHALLENGES
7.9.ENDO INTERNATIONAL PLC
7.9.1.OVERVIEW
7.9.2.PRODUCT PORTFOLIO
7.9.3.KEY STRENGTHS
7.9.4.KEY CHALLENGES
7.10.CANDELA MEDICAL CORPORATION
7.10.1.OVERVIEW
7.10.2.PRODUCT PORTFOLIO
7.10.3.KEY STRENGTHS
7.10.4.KEY CHALLENGES
8. RESEARCH METHODOLOGY & SCOPE
8.1.RESEARCH SCOPE & DELIVERABLES
8.1.1.OBJECTIVES OF STUDY
8.1.2.SCOPE OF STUDY
8.2.SOURCES OF DATA
8.2.1.PRIMARY DATA SOURCES
8.2.2.SECONDARY DATA SOURCES
8.3.RESEARCH METHODOLOGY
8.3.1.EVALUATION OF THE PROPOSED MARKET
8.3.2.IDENTIFICATION OF DATA SOURCES
8.3.3.ASSESSMENT OF MARKET DETERMINANTS
8.3.4.DATA COLLECTION
8.3.5.DATA VALIDATION & ANALYSIS

TABLE LIST
TABLE 1: LATIN AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: LATIN AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: LATIN AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: LATIN AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: LATIN AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

FIGURE LIST
FIGURE 1: MARKET MATURITY ANALYSIS
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: KEY BUYING IMPACT ANALYSIS
FIGURE 4: LATIN AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)
FIGURE 5: LATIN AMERICA CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 6: LATIN AMERICA CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 7: LATIN AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)
FIGURE 8: LATIN AMERICA CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 9: LATIN AMERICA CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 10: LATIN AMERICA CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: LATIN AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: LATIN AMERICA CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: LATIN AMERICA CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030 (IN $ MILLION)
FIGURE 14: LATIN AMERICA CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 15: LATIN AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: BRAZIL CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: MEXICO CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: REST OF LATIN AMERICA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)

ページTOPに戻る



List of Tables/Graphs

TABLE LIST
TABLE 1: LATIN AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: LATIN AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: LATIN AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: LATIN AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: LATIN AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Triton Market Research社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:571 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68a805fa34b2e0_16717164() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68a805fa26a288_46622063() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 571